Recent Insider Transactions - Mineralys Therapeutics (NASDAQ: MLYS)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

08/12/2024

Sell

$1.08

6,348

$7K

177,135

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

08/12/2024

Buy

$1.08

6,348

$7K

114,238

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

08/12/2024

Buy

$0.54

5,017

$3K

107,890

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

08/12/2024

Sell

$0.54

5,017

$3K

25,087

NASDAQ MLYS Mineralys Therapeutics

Slingsby Brian Taylor / director, 10 percent owner:

07/24/2024

Sell

$13.05

550,000

$7.178M

8.64M

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

07/16/2024

Sell

$1.08

525

$567

183,483

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

07/16/2024

Buy

$1.08

525

$567

103,398

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

07/16/2024

Sell

$15.00

525

$8K

102,873

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

07/12/2024

Sell

$1.08

6,349

$7K

184,008

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

07/12/2024

Buy

$1.08

6,349

$7K

102,873

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

07/11/2024

Buy

$0.54

5,017

$3K

96,524

NASDAQ MLYS Mineralys Therapeutics

Rodman David Malcom / officer: Chief Medical Officer

07/11/2024

Sell

$0.54

5,017

$3K

30,104

NASDAQ MLYS Mineralys Therapeutics

Levy Adam Scott / officer: CFO and Secretary

07/11/2024

Sell

$13.14

10,757

$141K

247,611

NASDAQ MLYS Mineralys Therapeutics

Congleton Jon / director, officer: Chief Executive Officer

07/11/2024

Sell

$13.34

15,746

$210K

911,212